This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gillespie, S. K. Articles by Hersey, P. Search for Related Content PubMed PubMed Citation Articles by Gillespie, S. K. Articles by Hersey, P.

Oncology and Immunology Unit, Royal Newcastle Hospital, Newcastle, New South Wales, Australia

Requests for reprints: Peter Hersey, Oncology & Immunology Unit, Royal Newcastle Hospital, Room 443, David Maddison Building, Corner King and Watt Streets, Newcastle, New South Wales, Australia. Phone: 61-2492-36828; Fax: 61-2492-36184. E-mail: peter.hersey{at}newcastle.edu.au

Ingenol 3-angelate (PEP005), one of the active ingredients in an extract from Euphorbia peplus, was shown in preclinical studies to have activity against human melanoma xenografts in nude mice. In the present study, we have tested its ability to induce the apoptosis of melanoma cells in vitro in the absence or presence of tumor necrosis factor-related apoptosis inducing ligand (TRAIL). The results showed that at relatively high concentrations (100 µg/mL), PEP005 killed melanoma cells mainly by induction of necrosis. In 20% of cell lines, evidence of apoptosis was observed. Apoptosis was caspase-dependent and associated with changes in mitochondrial membrane potential that were not inhibitable by overexpression of Bcl-2 or inhibition of caspases but were blocked by inhibition of protein kinase C (PKC). Low concentrations (1 or 10 µg/mL) of PEP005 either increased or decreased TRAIL-induced apoptosis in a cell line–dependent manner. These changes in TRAIL-induced apoptosis seemed to be due to activation of PKC and varying levels of PKC isoenzymes in different melanoma cell lines. PEP005-mediated enhancement of apoptosis seemed to be associated with low expression of the PKC isoform. These results indicate that PEP005 may enhance or inhibit sensitivity of melanoma to treatments associated with TRAIL-induced apoptosis depending on the PKC isoform content of melanoma cells.

Key Words: PEP005 • TRAIL • PKC • Apoptosis • Ingenol 3-angelate • Euphorbia peplus

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely toindicate this fact.

Received 7/13/04; revised 1/10/04; accepted 10/ 7/04.